BRTX vs DASH · rev $401.0K vs P/E 76, rev $13.72B
BioRestorative Therapies Inc (BRTX) versus DoorDash, Inc. Class A Common Stock (DASH) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
BRTX currently screens at market cap $10.2M. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Not investment advice. Open the BRTX and DASH stock pages for the full models.
Not investment advice.